MedPath

ADROVANCE 70 MG/2.800 UI COMPRIMIDOS

ADROVANCE 70 MG/2.800 UI COMPRIMIDOS

Pending
Register Number

06364002IP

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jul 11, 2025

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number06364002IP
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

ALENDRONATO SODIO TRIHIDRATOActive
Quantity: 70 mg
Name: ALENDRONATO SODIO TRIHIDRATO
COLECALCIFEROLActive
Quantity: 2800 UI
Name: COLECALCIFEROL

ATC CLASSIFICATION (3)

M05B
M05BB
M05BB03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.